Search company, investor...

Predict your next investment

Venture Capital
newtonbiocapital.com

See what CB Insights has to offer

Investments

16

Portfolio Exits

2

Funds

2

About Newton Biocapital

Newton Biocapital is a Belgian venture capital fund focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases. The fund's approach as lead investor is to support start-up projects, as well as undervalued late-stage projects, in order to mitigate the risks and to create investor value.

Headquarters Location

Tervurenlaan 273

Brussels, 1150,

Belgium

+32 2 899 7850

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Newton Biocapital News

Newton Biocapital implements PE Front Office to manage its Deal Pipeline - ED Times

Jul 13, 2022

Pipeline - ED Times Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN

Newton Biocapital Investments

16 Investments

Newton Biocapital has made 16 investments. Their latest investment was in Synergia Medical as part of their Series B on September 9, 2022.

CBI Logo

Newton Biocapital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/12/2022

Series B

Synergia Medical

$9.11M

No

1

9/9/2021

Series C - IV

PRISM BioLab

$11.85M

Yes

2

6/22/2021

Series A

NeuVasQ Biotechnologies

$23.88M

Yes

3

5/7/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

2/24/2021

Seed VC

Subscribe to see more

Subscribe to see more

10

Date

9/12/2022

9/9/2021

6/22/2021

5/7/2021

2/24/2021

Round

Series B

Series C - IV

Series A

Series B

Seed VC

Company

Synergia Medical

PRISM BioLab

NeuVasQ Biotechnologies

Subscribe to see more

Subscribe to see more

Amount

$9.11M

$11.85M

$23.88M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

2

3

10

10

Newton Biocapital Portfolio Exits

2 Portfolio Exits

Newton Biocapital has 2 portfolio exits. Their latest portfolio exit was Acticor Biotech on November 02, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/2/2021

IPO

$99M

Public

1

6/22/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/2/2021

6/22/2021

Exit

IPO

IPO

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Public

Subscribe to see more

Sources

1

10

Newton Biocapital Fund History

2 Fund Histories

Newton Biocapital has 2 funds, including Newton Biocapital II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

2/15/2022

Newton Biocapital II

$56.65M

1

1/7/2019

Newton Biocapital I Pricaf Privee

10

Closing Date

2/15/2022

1/7/2019

Fund

Newton Biocapital II

Newton Biocapital I Pricaf Privee

Fund Type

Status

Amount

$56.65M

Sources

1

10

Newton Biocapital Team

1 Team Member

Newton Biocapital has 1 team member, including current Founder, Managing Partner, Alain Parthoens.

Name

Work History

Title

Status

Alain Parthoens

Founder, Managing Partner

Current

Name

Alain Parthoens

Work History

Title

Founder, Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.